Audio Recording of Earnings Call pertaining to the audited Financial Results for the quarter and financial year ended March 31, 2026

STAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.6%1-day move

₹1105.00

prior close

₹1124.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-5.7-6.8-7.1-3.7+3.6+5.3+3.5+7.2+5.4+2.3-11.6+1.2-4.5—

Up moveDown movePending

AI summary

Strides Pharma Science has informed exchanges that the audio recording of its earnings call held on May 18, 2026, discussing audited financial results for Q4 and FY ended March 31, 2026, is now available on the company's website. The call was held at 17:00 hrs IST. This filing is a procedural disclosure under SEBI Listing Regulations 46 and 30, notifying investors where to access the earnings call recording. The actual financial results or management commentary details are not included in this filing itself.

Likely market impact

This filing is informational in nature and does not directly impact shareholders as it only announces the availability of the earnings call recording. Investors seeking details on Q4/FY2026 performance should access the recording on the Strides Pharma website directly.